Patient Selection & Assessment

Selecting the Right Patient

The CardioMEMS™ HF System is indicated for patients with:¹

• NYHA Class II or Class III heart failure; and
• One heart failure hospitalization in the past 12 months; and/or
• Have elevated natriuretic peptides

The CardioMEMS HF System is contraindicated for patients with:

• An inability to take dual antiplatelet or anticoagulants for one-month post implant

Patients who most commonly receive the CardioMEMS HF System are those on GDMT and those who exhibit any of the following:²

• Fluid volumes that are hard to know or manage
• Challenging physical assessment
• Is a patient with HFpEF or HFrEF
• Compliant with heart failure medical care
• Would benefit from remote monitoring if they live far from a clinic

Note: The CHAMPION trial specifically excluded patients with American College of Cardiology/ American Heart Association stage D heart failure who needed advanced therapies (i.e., left ventricular assist device, transplant or inotropic support). Even if inotropic support improved heart failure symptoms, a patient would still be defined as stage D, with refractory heart failure.²